参考文献/References:
［1］吴莎，华清泉，杨琨，等．脑源性神经营养因子研究进展 ［J］．中华临床医师杂志（电子版），2013，7（9）：3988-3990．
［2］SANTULLI P, MARCELLIN L, TOSTI C, et al. MAP kinases and the inflammatory signaling cascade as targets for the treatment of endometriosis? ［J］. Expert Opinion on Therapeutic Targets, 2015, 19(11): 1465-1483.
［3］BAI Huimin, LI Haixia, LI Weihua, et al. The PI3K/AKT/mTOR pathway is a potential predictor of distinct invasive and migratory capacities in human ovarian cancer cell lines ［J］. Oncotarget, 2015, 6(28): 25520-25532.
［4］LECONTE M, NICCO C, NG C, et al. The mTOR/AKT inhibitor temsirolimus prevents deep infiltrating endometriosis in mice ［J］. The American Journal of Pathology, 2011, 179(2): 880-889.
［5］USUI T, NARUO A, OKADA M, et al. Brain-derived neurotrophic factor promotes angiogenic tube formation through Generation of oxidative stress in human vascular endothelial cells ［J］. Acta Physiologica (Oxford, England), 2014, 211(2): 385-394.
［6］BLAIS M, L VESQUE P, BELLENFANT S, et al. Nerve growth factor, brain-derived neurotrophic factor, neurotrophin-3 and glial-derived neurotrophic factor enhance angiogenesis in a tissue-engineered in vitro model ［J］. Tissue Engineering Part a, 2013, 19(15/16): 1655-1664.
［7］KIM T H, YU Yanni, LUO L, et al. Activated AKT pathway promotes establishment of endometriosis ［J］. Endocrinology, 2014, 155(5): 1921-1930.
［8］中华医学会妇产科学分会子宫内膜异位症协作组．子宫内膜异位症的诊治指南 ［J］．中华妇产科杂志，2015，50（3）：161-169．
［9］ANGER D L, ZHANG Bingjun, BOUTROSS-TADROSS O, et al. Tyrosine receptor kinase B (TrkB) protein expression in the human endometrium ［J］. Endocrine, 2007, 31(2): 167-173.
［10］BROWNE A S, YU Jie, HUANG Ruo-pan, et al. Proteomic identification of neurotrophins in the eutopic endometrium of women with endometriosis ［J］. Fertility and Sterility, 2012, 98(3): 713-719.
［11］雍敏婕，李文倩，王芳，等．ER与TrkB在子宫内膜异位症患者不同子宫内膜组织中的表达 ［J］．国际妇产科学杂志，2015，42 （5）：500-503．
［12］RUIZ A, ROCKFIELD S, TARAN N, et al. Effect of hydroxychloroquine and characterization of autophagy in a mouse model of endometriosis ［J］. Cell Death & Disease, 2016, 7(1): e2059.
［13］TAYLOR R N, YU Jie, TORRES P B, et al. Mechanistic and therapeutic implications of angiogenesis in endometriosis ［J］. Reproductive Sciences, 2009, 16(2): 140-146.
［14］Borghese B, Vaiman D, Mondon F, et al. Neurotrophins and pain in endometriosis ［J］. Gynecol Obstet Fertil,2010,38(7-8):442-446.
［15］MOROTTI M, VINCENT K, BRAWN J, et al.Peripheral changes in endometriosis-associated pain ［J］. Human Reproduction Update, 2014, 20(5): 717-736.
［16］代淑红，马正良．钾氯共转运体-2和痛觉过敏关系的研究进展 ［J］．国际麻醉学与复苏杂志，2015，36（6）：543-546．
［17］WESSELS J M, LEYLAND N A, AGARWAL S K. Estrogen induced changes in uterine brain-derived neurotrophic factor and its receptors ［J］. Human Reproduction, 2015, 30(4): 925-936.
［18］WESSELS J M, KAY V R, LEYLAND N A, et al. Assessing brain-derived neurotrophic factor as a novel clinical marker of endometriosis ［J］. Fertility and Sterility, 2016, 105(1): 119-128.e1.
相似文献/References:
[1]苏慧明,徐燕,李晶,等.E-钙粘附素在子宫内膜异位症盆腔腹膜病灶的表达[J].中国计划生育和妇产科,2010,(01):0.
SU Hui-ming,XU Yan,LI Jing,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(3):0.
[2]李桂兰.青春期子宫内膜异位症的诊治进展[J].中国计划生育和妇产科,2010,(03):0.
[3]韦晓娜,覃红萍.孕三烯酮配伍小剂量米非司酮治疗子宫内膜异位症64例效果观察[J].中国计划生育和妇产科,2010,(04):0.
[4]李成龙,冷金花.子宫内膜异位症与雌、孕激素受体关系的研究进展[J].中国计划生育和妇产科,2010,(04):0.
[5]关铮.深部浸润型子宫内膜异位症相关问题探讨[J].中国计划生育和妇产科,2011,(04):0.
[6]张瑞霞,刘增娟,谢伟,等.腹腔镜诊断盆腔子宫内膜异位症及对不孕症患者的疗效观察[J].中国计划生育和妇产科,2012,(02):0.
ZHANG Rui-xia,LIU Zeng-juan,XIE Wei,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(3):0.
[7]梁寿珺,范余娟,黄尹,等.血管内皮生长因子+936TC基因多态性同子宫内膜异位症遗传易感性的Meta分析[J].中国计划生育和妇产科,2012,(04):0.
LIANG Shou-jun,FAN Yu-juan*,HUANG Yin,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(3):0.
[8]范俊,栾少红,李晓林,等.口服避孕药在子宫内膜异位症治疗中的作用[J].中国计划生育和妇产科,2013,(02):0.
FAN Jun,LUAN Shao-hong,LI Xiao-lin,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(3):0.
[9]柴明涵,董白桦.左炔诺孕酮宫内缓释系统的临床应用[J].中国计划生育和妇产科,2014,(03):0.
[10]李素红,冯春蝶,付秀虹,等.Treg细胞及Foxp3在子宫内膜异位症患者的表达及临床意义[J].中国计划生育和妇产科,2014,(04):0.
LI Su-hong,FENG Chun-die,FU Xiu-hong,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(3):0.
[11]洪玮,段华*,汪沙.脑源性神经营养因子与受体在子宫内膜异位症
发生发展及相关症状中作用的研究进展[J].中国计划生育和妇产科,2017,(3):27.
[12]吴亚男,李红霞*,孟宪宁,等.子宫内膜异位症及卵巢癌患者血清脑源性神经营养因子水平的表达及意义[J].中国计划生育和妇产科,2018,(9):32.
WU Ya-nan,LI Hong-xia*,MENG Xian-ning,et al.Expression and significance of serum BDNF in patients with endometriosis and ovarian cancer[J].Chinese Journal of Family Planning & Gynecotokology,2018,(3):32.